OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer vaccine: learning lessons from immune checkpoint inhibitors
Zhenlong Ye, Qiming Qian, Huajun Jin, et al.
Journal of Cancer (2017) Vol. 9, Iss. 2, pp. 263-268
Open Access | Times Cited: 41
Zhenlong Ye, Qiming Qian, Huajun Jin, et al.
Journal of Cancer (2017) Vol. 9, Iss. 2, pp. 263-268
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Current status and future directions of cancer immunotherapy
Hongming Zhang, Jibei Chen
Journal of Cancer (2018) Vol. 9, Iss. 10, pp. 1773-1781
Open Access | Times Cited: 323
Hongming Zhang, Jibei Chen
Journal of Cancer (2018) Vol. 9, Iss. 10, pp. 1773-1781
Open Access | Times Cited: 323
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6845-6862
Open Access | Times Cited: 38
Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 6845-6862
Open Access | Times Cited: 38
Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, et al.
Pharmacological Research (2019) Vol. 147, pp. 104353-104353
Closed Access | Times Cited: 139
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, et al.
Pharmacological Research (2019) Vol. 147, pp. 104353-104353
Closed Access | Times Cited: 139
Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill M. Comeau, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 779-779
Open Access | Times Cited: 69
Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill M. Comeau, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 779-779
Open Access | Times Cited: 69
Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines
Candido G. Da Silva, Marcel Camps, Tracy Li, et al.
Biomaterials (2019) Vol. 220, pp. 119417-119417
Closed Access | Times Cited: 76
Candido G. Da Silva, Marcel Camps, Tracy Li, et al.
Biomaterials (2019) Vol. 220, pp. 119417-119417
Closed Access | Times Cited: 76
Curcumin as an Adjuvant to Cancer Immunotherapy
Silpita Paul, Gaurisankar Sa
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 48
Silpita Paul, Gaurisankar Sa
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 48
Cancer neoantigens as potential targets for immunotherapy
Weijie Ma, Brian Pham, Tianhong Li
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 1, pp. 51-60
Open Access | Times Cited: 44
Weijie Ma, Brian Pham, Tianhong Li
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 1, pp. 51-60
Open Access | Times Cited: 44
Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine
Jihye Hong, Mungyo Jung, Cheesue Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 541-554
Open Access | Times Cited: 18
Jihye Hong, Mungyo Jung, Cheesue Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 541-554
Open Access | Times Cited: 18
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response
Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 3, pp. 1036-1049
Open Access | Times Cited: 57
Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 3, pp. 1036-1049
Open Access | Times Cited: 57
Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy
Eliran Moshe Reuven, Shani Leviatan Ben‐Arye, Hai Yu, et al.
ACS Nano (2019) Vol. 13, Iss. 3, pp. 2936-2947
Open Access | Times Cited: 49
Eliran Moshe Reuven, Shani Leviatan Ben‐Arye, Hai Yu, et al.
ACS Nano (2019) Vol. 13, Iss. 3, pp. 2936-2947
Open Access | Times Cited: 49
Extracellular Vesicles and Their Current Role in Cancer Immunotherapy
Carla Giacobino, Marta Canta, Cristina Fornaguera, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 34
Carla Giacobino, Marta Canta, Cristina Fornaguera, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 34
A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches
Bhanu P. Sahu, Rinku Baishya, Jyoti Lakshmi Hatiboruah, et al.
Journal of Pharmaceutical Investigation (2022) Vol. 52, Iss. 5, pp. 539-585
Closed Access | Times Cited: 23
Bhanu P. Sahu, Rinku Baishya, Jyoti Lakshmi Hatiboruah, et al.
Journal of Pharmaceutical Investigation (2022) Vol. 52, Iss. 5, pp. 539-585
Closed Access | Times Cited: 23
B-Cell Epitope Peptide Cancer Vaccines: A New Paradigm for Combination Immunotherapies with Novel Checkpoint Peptide Vaccine
Pravin T. P. Kaumaya
Future Oncology (2020) Vol. 16, Iss. 23, pp. 1767-1791
Open Access | Times Cited: 33
Pravin T. P. Kaumaya
Future Oncology (2020) Vol. 16, Iss. 23, pp. 1767-1791
Open Access | Times Cited: 33
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer
Hannah E. Bergom, Laura A. Sena, Abderrahman Day, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Hannah E. Bergom, Laura A. Sena, Abderrahman Day, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Current Landscape of Therapeutic Cancer Vaccines
Inbal Rosenthal, Vered Padler‐Karavani
Methods in molecular biology (2025), pp. 1-14
Closed Access
Inbal Rosenthal, Vered Padler‐Karavani
Methods in molecular biology (2025), pp. 1-14
Closed Access
Potentiating cancer vaccine efficacy in liver cancer
Maria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, et al.
OncoImmunology (2018) Vol. 7, Iss. 10, pp. e1488564-e1488564
Open Access | Times Cited: 33
Maria Tagliamonte, Annacarmen Petrizzo, Angela Mauriello, et al.
OncoImmunology (2018) Vol. 7, Iss. 10, pp. e1488564-e1488564
Open Access | Times Cited: 33
MAIT cells as attractive vaccine targets
A. Michael Downey, Paulina Kapłonek, Peter H. Seeberger
FEBS Letters (2019) Vol. 593, Iss. 13, pp. 1627-1640
Open Access | Times Cited: 33
A. Michael Downey, Paulina Kapłonek, Peter H. Seeberger
FEBS Letters (2019) Vol. 593, Iss. 13, pp. 1627-1640
Open Access | Times Cited: 33
Is adaptive therapy natural?
Frédéric Thomas, Emmanuel Donnadieu, Guillaume M. Charrière, et al.
PLoS Biology (2018) Vol. 16, Iss. 10, pp. e2007066-e2007066
Open Access | Times Cited: 26
Frédéric Thomas, Emmanuel Donnadieu, Guillaume M. Charrière, et al.
PLoS Biology (2018) Vol. 16, Iss. 10, pp. e2007066-e2007066
Open Access | Times Cited: 26
ICI-based therapies: A new strategy for oral potentially malignant disorders
Tianqing Wang, Silu Sun, Xin Zeng, et al.
Oral Oncology (2023) Vol. 140, pp. 106388-106388
Closed Access | Times Cited: 7
Tianqing Wang, Silu Sun, Xin Zeng, et al.
Oral Oncology (2023) Vol. 140, pp. 106388-106388
Closed Access | Times Cited: 7
Ecological and Evolutionary Consequences of Anticancer Adaptations
Justine Boutry, Antoine M. Dujon, Anne‐Lise Gérard, et al.
iScience (2020) Vol. 23, Iss. 11, pp. 101716-101716
Open Access | Times Cited: 18
Justine Boutry, Antoine M. Dujon, Anne‐Lise Gérard, et al.
iScience (2020) Vol. 23, Iss. 11, pp. 101716-101716
Open Access | Times Cited: 18
Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma
Chenming Zou, Guiying Jiang, Xueqin Gao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 22, pp. 102092-102092
Closed Access | Times Cited: 16
Chenming Zou, Guiying Jiang, Xueqin Gao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 22, pp. 102092-102092
Closed Access | Times Cited: 16
Complex dynamics of a tumor-immune system with antigenicity
Jianquan Li, Xin Xie, Yuming Chen, et al.
Applied Mathematics and Computation (2021) Vol. 400, pp. 126052-126052
Closed Access | Times Cited: 12
Jianquan Li, Xin Xie, Yuming Chen, et al.
Applied Mathematics and Computation (2021) Vol. 400, pp. 126052-126052
Closed Access | Times Cited: 12
New Strategies for Therapeutic Cancer Vaccines
Hanjiao Qin, Jiyao Sheng, Dan Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2018) Vol. 19, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Hanjiao Qin, Jiyao Sheng, Dan Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2018) Vol. 19, Iss. 2, pp. 213-221
Closed Access | Times Cited: 11
Integrating Bioinformatics Strategies in Cancer Immunotherapy: Current and Future Perspectives
Houda N. Washah, Elliasu Y. Salifu, Opeyemi Soremekun, et al.
Combinatorial Chemistry & High Throughput Screening (2020) Vol. 23, Iss. 8, pp. 687-698
Closed Access | Times Cited: 10
Houda N. Washah, Elliasu Y. Salifu, Opeyemi Soremekun, et al.
Combinatorial Chemistry & High Throughput Screening (2020) Vol. 23, Iss. 8, pp. 687-698
Closed Access | Times Cited: 10
Near infrared light activation of an injectable whole-cell cancer vaccine for cancer immunoprophylaxis and immunotherapy
Fei Wang, Junbin Gao, Shuanghu Wang, et al.
Biomaterials Science (2021) Vol. 9, Iss. 11, pp. 3945-3953
Closed Access | Times Cited: 8
Fei Wang, Junbin Gao, Shuanghu Wang, et al.
Biomaterials Science (2021) Vol. 9, Iss. 11, pp. 3945-3953
Closed Access | Times Cited: 8
